Sunday Roast-Tim, CEO #IMM
16 March 2025
ImmuPharma’s CEO, Tim McCarthy talks again to Sunday Roast investment podcast, to give detail on the recent announcement on the mechanism of action of IMMs autoimmune P140 technology and how important this is in current and future business development discussions – March 2025